Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression

Author(s):
Wissing, M.D.; Dadon, T.; Kim, E.; Piontek, K.B.; Shim, J.S.; Kaelber, N.S.; Liu, J.O.; Kachhap, S.K.; Nelkin, B.D.
Published
2014
Publication type
Article / Letter to editor
tiloronesynthetic lethalitycyclin-dependent kinase 5prostate cancer
Date issued
2014-07-31
Language
English
Is part of
Oncology Reports (2014), Vol. 32, no. 1, p. 419-424
hdl
1887/104648
doi
10.3892/or.2014.3174